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“A COMPARATIVE STUDY OF LOW DOSE INTRATHECAL 
BUPIVACAINE WITH EPIDURAL VOLUME EXPANSION AND 
CONVENTIONAL DOSE SPINAL ANAESTHESIA IN CAESAREAN 
SECTIONS” 
ABSTRACT: 
BACKGROUND:     Subarachnoid block (SAB) is a commonly used technique 
of regional anaesthesia in caesarean sections. Among the adverse effects 
associated with SAB, Hypotension and bradycardia which are encountered 
commonly can have fatal effect both on mother and fetus. So a search for an 
alternative technique is on for a long time.  Epidural Volume Expansion(EVE) 
via a combined spinal epidural (CSE) technique is the enhancement of a small 
dose intrathecal block by epidural saline boluses. 
AIM:   To compare the Epidural Volume Expansion of low dose intrathecal 
Bupivacaine and conventional dose spinal anaesthesia in caesarean sections 
with respect to its sensory and motor block profile and hemodynamic stability in 
caesarean sections. 
METHODOLGY:  In this double blinded, randomised control, prospective 
study, sixty parturients undergoing caesarean sections under CSE anaesthesia 
were assigned randomly into two groups(n= 30) group S and group E. Group S 
received 9mg of 0.5% hyperbaric Bupivacaine with 10 mcg of Fentanyl. Group 
E received 5 mg of 0.5% of hyperbaric Bupivacaine with 10 mcg of Fentanyl 
followed by EVE with 6 ml of saline within 3 minutes of subarachnoid 
injection. Patients pulse rate, Mean Arterial Pressure (MAP) was monitored 
every 2.5 minutes. Highest sensory and motor levels achieved, time required for 
achieving highest sensory and motor levels and block regression, any 
perioperative adverse effects were recorded.     
   RESULTS:  The maximum sensory level achieved was similar in both the 
groups. The motor levels were significantly lower in group E. Block regression 
was significantly earlier in group E. MAP was maintained at higher levels in 
group E. The time for request of rescue analgesia was earlier in group E. 
COCLUSION: In comparision to conventional dose spinal anaesthesia, EVE 
provides adequate intraoperative analgesia, faster blockade recovery and better 
hemodynamic stability in caesarean sections.   
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INTRODUCTION 
“The delivery of the infant into the arms of a conscious and pain free 
mother is One of the most exciting and rewarding moments in medicine” 
says Moir. 
An increasing number of parturients wish to be awake during 
caesarean section
 [1]
 and opt for regional rather than general anaesthesia. 
Subarachnoid block [SAB] is a time honoured simple regional technique 
which requires a small dose of intrathecal drug to provide surgical 
anaesthesia with rapid, intense and reliable neuraxial block. Since from 
1901, when Kreis
[2]
  described the first subarachnoid block  for vaginal 
delivery, SAB for labor and delivery has progressed greatly. Though SAB is 
a commonly preferred conventional technique for caesarean sections, the 
incidence of spectrum of complications persists even today. Hypotension 
and bradycardia that are more common are of chief concern as they have an 
effect both on mother and the fetus. 
Conventional dose
[3]
 of drugs in SAB for caesarean sections often 
produce rapid onset of a dense block that causes significant hemodynamic 
instability and residual motor blockade, which usually lasts beyond the 
duration of surgery demanding prolonged post operative anaesthesia care. 
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This could also lead to maternal anxiety. Even it does not provide post 
operative analgesia for longer time. 
A search for alternative anaesthetic techniques to overcome these 
problems is on for a long time. Epidural Volume Expansion(EVE) is a 
modification of conventional sequential Combined Spinal Epidural(CSE) 
technique, in which SAB is induced with intrathecal local anaesthetic with 
or without  opioids to produce a  block which can be extended with epidural 
top ups of  local anaesthetics or saline. Most of the studies
[ 5,6,7,8 ]
 available 
in the literature have evaluated this technique using a conventional dose of 
intrathecal drug and have demonstrated a higher level of blockade and better 
post operative pain relief in comparison to SAB alone. 
There are only few studies
[9,10]
 which have used low dose intrathecal 
drug for this technique and demonstrated a better hemodynamic stability 
with faster motor recovery. These findings open a newer avenue to ensure 
patient safety with minimal hemodynamic fluctuations and better post 
operative pain relief in obstetric anaesthesia. 
Hence this study was taken up to compare the low dose intrathecal 
Bupivacaine with EVE technique and conventional dose single shot spinal 
anaesthesia in caesarean sections.    
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                                        AIM OF THE STUDY 
The Aim of this study is to compare low dose intrathecal Bupivacaine 
with Epidural Volume Expansion and conventional dose spinal anaesthesia 
in caesarean sections with respect to: 
                            a. Sensory block profile 
                            b. Motor block profile and 
                            c. Hemodynamic stability. 
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ANATOMY 
 
The spinal cord and its nerve roots are secured within the spinal canal 
or the vertebral column, a bony structure that extends from foramen 
magnum to sacral hiatus.  
The vertebral column is comprised of individual pre sacral vertebrae 
and fused sacral and coccygeal vertebrae: 
         Pre Sacral vertebrae            - Cervical vertebrae - 7 
                                                     - Thoracic vertebrae - 12 
                                                     - Lumbar vertebrae - 5 
           Sacral vertebrae                - 5  
           Coccygeal vertebrae          - 4 
  The vertebral canal exhibits four curvatures: 
                   Cervical and Lumbar concavity (lordosis) 
                   Thoracic and Sacral convexity (kyphosis) 
The thoracic convexity and lumbar lordosis are of importance in 
spread of  local anaesthetic drug in spinal canal.   
Anteriorly the vertebral bodies and intervertebral discs are connected 
and supported by the anterior and posterior longitudinal ligaments and 
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posteriorly, the posterior longitudinal ligaments, ligamentum flavum, 
interspinous ligamentum, supraspinous ligaments provide further stability. 
             The thickness of ligamentum flavum and its distance from skin 
varies in different regions. It is of clinical importance while performing 
neuraxial blockades.  
Site Skin to ligament (cm) 
Thickness of Ligament 
(mm) 
    Cervical              _    1.5-3.0 
    Thoracic               _    3.0-5.0 
    Lumbar             3-8     5-6 
    Caudal         Variable     2-6 
 
Spinal Cord: 
                  The spinal cord is the direct continuation of the medulla 
oblongata. It begins at the upper border of the Atlas and terminates in the 
Conus medullaris. Within the vertebral column it is surrounded by its 
coverings (meninges), venous plexus and fatty tissue. In term newborn, it 
extends down to the lower border of L3. Later in adolescence the spinal 
cord attains its adult position, ending at the level of the intervertebral disk 
between L1 and L2 due to the differential growth rates between the bony 
vertebral canal and the spinal cord. 
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          Surrounding the spinal cord in the spinal column are three membranes 
(from within to the periphery):  
                  1. Piamater 
                  2. Arachnoid mater and  
                  3. Duramater.  
       The piamater is highly vascular that closely invests the spinal cord. The 
arachnoid mater is a neovascular membrane closely attached to the 
outermost duramater. Between the two membranes is the subarachnoid 
space which contains cerebrospinal fluid, spinal nerve roots, blood vessels 
that supply the spinal cord and the denticulate ligaments. The subarachnoid 
space continues distally upto S2. 
          The duramatar, outermost membrane in the spinal canal is a 
longitudinally organized fibroelastic membrane. This layer is the direct 
extension of the cranial duramater and extends down from the foramen 
magnum to S2, where the filum terminale (an extension of the piamater 
beginning at the conus medullaris) blends with the periosteum of the 
subdural space which contains only small amounts of serous fluids to allow 
the dura and arachnoid move over each other.  
Surrounding the duramater is the epidural space which extends from 
the foramen magnum to the sacral hiatus. It is bounded cranially by foramen 
magnum, caudally by the sacrococcygeal ligament, anteriorly by the 
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posterior longitudinal ligament, laterally by vertebral pedicles of the 
vertebrae and posteriorly by ligamentum flavum and vertebral lamina. It 
communicates with paravertebral space through intervetebral foramina. 
   The depth of epidural space varies at different levels: maximal 
about 6 mm at L2, 4-5 mm in the midthoracic region and roughly 3 mm 
where the lumbar and cervical enlargements of the spinal canal encroach on 
it. 
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                                SPINAL ANAESTHESIA 
                  Spinal anaesthesia (subarachnoid block or intrathecal block) is 
the most frequently used method of regional anaesthesia. It is a form of 
central neuraxial block which involves the use of small amounts of local 
anaesthetics with or without adjuvant solutions injected into the 
subarachnoid space to produce a reversible loss of sensation and motor 
function. 
 History of spinal anaesthesia dates back to 1891 when Essex Wynter 
in 1891
[14]
 described dural puncture. Augustus Karl Gustav Bier, a 
German surgeon, used cocaine intrathecally for lower extremity surgery in 
1898
[15]
. 
ADVANTAGES OF SPINAL ANAESTHESIA: 
1. Easy to perform.  
 2.  Provides excellent operating conditions.  
 3.  Economical than general anaesthesia.  
 4.  Maintenance of patent airway.  
 5.  Lesser pulmonary complications compared to general anaesthesia. 
 6. Decreased incidence of deep vein thrombosis and pulmonary 
emboli.  
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DISADVANTAGES OF SPINAL ANAESTHESIA:  
1. Risk of failure.  
2.  Alteration in the patient‟s hemodynamics. 
3. Shorter duration of post operative pain relief. 
PHYSIOLOGY OF SUBARACHNOID BLOCK: 
CEREBROSPINAL FLUID: 
                        The cerebrospinal fluid is an ultra filtrate of  blood 
plasma. It is secreted by the choroidal plexus at a rate of 0.3-
0.4ml/minute. It is clear, colourless, fluid present in the spinal and 
cranial subarachnoid spaces and in the ventricles of the brain. In adults 
average volume ranges from 120-150ml. This fluid is distributed in 
ventricles (35 ml), cerebral subarachnoid space (25 ml) and spinal 
subarachnoid space (75ml). 
      Physical characteristics of CSF: 
PH 7.4 
    Specific gravity ( Body temperature) 
                              ( At 4
0
 C) 
1.007  
1.0003 
Density 1.0003g/ml 
Baricity 1.000 
Pressure in supine position 8-12mm Hg 
Cells 3-5/cu.mm 
Proteins 20 mg/dl 
Glucose 45-80 mg/dl 
10 
 
 
 Mechanism of Action of intrathecal local anaesthetics:  
  Local anaesthetics administered in the subarachnoid space block 
sensory, motor and autonomic impulses as nerve roots pass through the 
CSF. The site of action includes the spinal nerve roots and dorsal root 
ganglion. Local anaesthetics block the sodium channels and propagation of 
action potential along the nerve root. 
Uptake & Elimination of Spinal Anaesthetics:  
Factors that affect the uptake of local anaesthetics in the subarachnoid 
space:  
 1.  Concentration of local anaesthetic.  
 2. Surface area of nerve tissue exposed.  
 3. Lipid content of the neuronal tissue.  
 4. Blood flow to the tissue.  
           Concentration of local anaesthetic is highest at the site of injection. 
Spinal nerve roots lack an epineurium and are easily blocked. As the local 
anaesthetic diffuses away from the initial site of injection, its concentration 
decreases secondary to absorption into neural tissue and dilution by the 
CSF. Spinal cord tissue absorbs local anesthetics through the pia mater and 
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the spaces of Virchow-Robin, which are extensions of the subarachnoid 
space. However, the site of action is not the spinal cord, but the spinal 
nerves and dorsal root ganglia.  
           Elimination occurs through vascular absorption in the subarachnoid 
and epidural space. The rate of absorption is proportional to the vascular 
surface area that the local anaesthetic comes into contact with. Lipid 
solubility of the local anaesthetic solution increases the uptake into the 
tissue, further diluting the concentration. Local anaesthetics also diffuse into 
the epidural space along a concentration gradient. Once in the epidural 
space, diffusion into the epidural vasculature occurs. 
Zones of differential blockade: 
             In SAB, sympathetic blockade level is usually two to three 
segments higher than sensory level. Sympathetic block is intense when more 
concentrated solutions are used. The motor block attained is two segments 
lower than the sensory block. 
 Order of nerve blockade: 
      -  Autonomic preganglionic beta fibres. 
      -  Temperature fibres. 
 -   Fibers conveying pinprick. 
 -  Fibers conveying pain greater than pin prick. 
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      -  Touch fibers. 
      -  Deep pressure fibers. 
      -  Somatic motor fibers. 
      -  Fibers conveying vibratory sense and proprioceptic impulses. 
             During recovery, return of sensations in the reverse order was 
assumed, but recent concepts suggest that sympathetic activity returns 
before senation. 
INDICATIONS: 
     1. Lower abdominal surgery. 
     2. Lower limb surgery.  
     3. Perineal and rectal surgery. 
    4. Urological surgery. 
    5. Obstetric and gynaecological surgery. 
CONTRA INDICATIONS: 
Absolute:         1. Patient refusal 
                    2. Infection at the site of injection 
                    3. Coagulopathy 
                    4. Hypovolemia. 
               5. Indeterminate neurologic disease. 
               6. Raised intracranial pressure. 
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Relative:        1. Infection distinct from the site of injection. 
                  2. Unknown duration of surgery. 
 
FACTORS AFFECTING THE SPREAD OF LOCAL ANAESTHETIC: 
 
Properties of local anaesthetic solution: 
             1. Baricity of the drug 
             2. Volume of the drug 
             3. Specific Gravity of the drug 
              4. Dose of the drug 
Patient characteristics: 
           1.  Position during and after injection. 
           2.  Height (extremely tall or short) 
           3.  Anatomy of the spinal column. 
           4.  Decreased volume of CSF eg: pregnancy, obesity. 
    Factors related to technique: 
          1. Site of injection. 
           2. Needle bevel direction. 
COMPLICATIONS OF SUB ARACHNOID BLOCK: 
   Immediate:     1. Hypotension 
                           2. Bradycardia 
                             3. Local anaesthetic toxicity due to intravascular injection. 
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                              4. High spinal block.  
                              5. Total spinal block. 
  Delayed:             1. Post Dural Puncture Headache 
                             2. Meningitis 
                             3. Arachnoiditis 
                             4. Anterior spinal artery syndrome. 
                             5. Cauda equina syndrome. 
                             6. Permanent neurologic injury.   
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COMBINED SPINAL EPIDURAL ANAESTHESIA 
             According to Steven and Edward the combination of two different 
anaesthesia administration routes on the same patient improves 
effectiveness and reduces side effect. The age-old single shot spinal 
anaesthesia provides fast and reliable segmental anaesthesia with very 
minimal risk for toxicity, while epidural anaesthesia provides perioperative 
anaesthesia followed by excellent analgesia in the postoperative period also. 
These two excellent techniques were combined for the first time in 
1937 by Dr A. Soresi, an Italian surgeon who injected drugs in the 
subarachnoid and epidural space at the same time 
[16 ]
. The procedure was 
described by Dr Soresi, as “Episubdural Anaesthesia” and involved use of 
the same fine needle for both the epidural and the spinal injection.                    
Dr. I Curelaru 
[ 17]
 performed the first combined spinal anaesthesia and 
catheter-based epidural anaesthesia in 1979 and published a study on it . He 
used Double Segment Technique (DST) for the study. This technique 
attracted a huge response only after Dr. Brownridge
[18]
 used this technique 
for elective caesarean sections successfully. 
               Later in 1982 Coates 
[19] 
and Mumtaz et al
[20]
described a technical 
innovation, introducing the “needle through needle” technique in lower limb  
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surgery. This novel technique was used for caesarean sections in 1984 by 
Carrie and O’Sullivan[21]. 
CLINICAL USES OF CSE: 
               CSE anaesthesia though was described originally for urologic 
surgery, indications for its use have expanded in last decade. CSE is now 
widely used in obstetrics (for labor analgesia and for caesarean sections),   
orthopaedic surgery, abdominal, .gynaecologic and vascular surgery. 
 They are indicated in: 
SURGERY TYPE PROCEDURES 
Obstetrics Labour analgesia, Caesarean section 
Abdominal surgery Colorectal, renal transplant 
Vascular surgery Infrarenal abdominal aortic aneurysm repair 
Gynaecology Hysterectomy 
Orthopaedics Hip and knee surgery 
Urology Prostatectomy, cystectomy 
 
TECHNIQUES OF CSEA: 
1. Needle through Needle Technique (NTN Technique):  
       Though Soresi described first “spinal-needle-through-epidural needle” 
technique by introducing the same needle into both the spaces, present day 
needle through needle techniques use separate spinal and epidural needles.   
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          After the epidural space is identified using an epidural needle, the 
epidural needle serves as introducer to the spinal needle, which is advanced 
through the epidural needle, beyond its tip, to punctures the dura. Drugs are 
first injected into the spinal space, and then the epidural catheter is inserted.  
Needle through Needle technique is the widely used CSE technique. 
Different types of this technique are also described.  
  1. A conventional Touhy needle can be used to identify the 
epidural space and a spinal needle which is longer than the usual needles, 
can be inserted through it to puncture the duramater.  
                     2. Specially designed epidural needles with a “Backeye” at the 
needle tip are also available and commonly used. This design allows smooth 
advancement of the spinal needle, without friction between the epidural 
catheter and the spinal needle, reduces the risk of epidural catheter 
migration through the holes created by the spinal needle .Eg: Huber Needle. 
              3. Double lumen needles in which a Touhy needle is equipped with 
a parallel tube that acts as a guide for a thinner spinal needle are available 
recently. They are of two types -bent parallel tube and a straight parallel 
tube. Eg: Eldor needle 
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2. Separate Needle Technique (SNT): 
            CSE may be performed using separate needles also. In this 
technique, the two components of CSE -spinal and epidural injection are 
performed by using separate needles, in the same or at different inter-
vertebral spaces (cook 2000
[22]
).  
 Comparison of Needle through needle and Separate Needle Technique: 
          The SNT technique has some theoretical advantages over the NTN 
technique.  
             1. It enables placement of the epidural catheter prior to initiation of 
the spinal block. Thus theoretically reducing the risk for neurologic injury, 
since paresthesia and other symptoms are not masked. 
           2. If hyperbaric solutions are used for subarachnoid injection in NTN 
technique, delayed catheter placement (technical problems) can result in 
fixation of the drug in the lower spaces. 
          3. Few studies have reported better success and lower failure rates 
with the SNT. However, these studies also report greater patient acceptance 
and less discomfort with the NTN technique. 
           4. The complication associated with NTN technique of metallic 
particles entering subarachnoid space is avoided with SNT technique 
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Pharmacological consideration: 
         CSE anaesthesia is an effective way to reduce drug doses required for 
anaesthesia or analgesia as the subarachnoid injection achieves rapid onset 
with minimal doses of local anaesthetics and opioids, which is further 
extended by epidural medication or saline. 
           CSE anaesthesia usually produces a more extensive block than 
expected, and the epidural dose needed to extend the block is often lower 
compared to doses needed with epidural anaesthesia alone .This observation 
was explained by two  possible explanations . 
                 1.  There is alleviation of sub atmospheric pressure by the Tuohy 
needle before injection of the local anaesthetics and can reduce the volume 
of the subarachnoid space in the dural sac and extend the level of 
anaesthesia
[ 23 ]
 
                   2. Diffusion of local anaesthetic molecules from the epidural to 
the subarachnoid space through the  hole in the duramatar due to dural sac 
compression after injection of local anaesthetic in the epidural space  
following dural puncture.
[ 4 ]
 
               Requirement of  Bupivacaine for CSE for caesarean section is 7.5-
15 mg combined with opioids. Recommended opioid doses are Fentanyl    
10-25 mcg and morphine 100-200mcg. Epidural top-ups of Bupivacaine or 
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Levobupivacaine 0.25 to 0.5% 10-40 mg with Fentanyl 25mcg or Sufentanil 
2.5-5mcg is recommended. With this doses adequate anaesthesia with 
slower onset of maternal hypotension and lesser incidence of adverse effects 
are documented. 
Advantages of CSE in Comparison With Conventional Epidural 
Or Subarachnoid Anaesthesia: 
1. When CSE block was compared with either epidural or 
subarachnoid block, it was found to be superior to epidural 
anaesthesia .Motor blockade was denser in CSE anaesthesia.  
2. Surgical anaesthesia is rapidly established, 15–20 min earlier 
compared with epidural anaesthesia. 
3. The epidural catheter provides the possibility of supplementing 
insufficient subarachnoid anaesthesia.  
4. CSE enables low-dose spinal anaesthesia for caesarean delivery. 
The presence of an epidural catheter as a “safety net” allows the 
anesthesiologist to use the lowest effective dose of local 
anaesthetic 
           Epidural volume extension (EVE) is a modified sequential CSE 
where enhancement of a small-dose intrathecal block by epidural saline 
injection has been demonstrated via a CSE technique. 
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  CSE in special population: 
1. Patients with significant cardiac or pulmonary disease: 
         CSE anaesthesia alone, without general anesthesia, can be a good 
anaesthetic option in patients with severe chronic obstructive pulmonary 
disease (COPD).  The safety of low-dose sequential CSE analgesia in 
women with unrepaired cyanotic heart disease who required analgesia for 
labor has recently been reported 
[24 ]
 
2. CSE anaesthesia in the elderly: 
         Several studies have investigated the use of CSE anaesthesia in 
geriatric patients. Few concluded that compared to spinal or epidural 
anaesthesia alone, CSE anaesthesia was preferred, providing rapid onset, 
reliable spinal block and high quality intraoperative and postoperative 
analgesia.  
           It was noted that in elderly patients (mean age 75.8 years) CSE 
anaesthesia provides sufficient anaesthesia with fewer complications than 
spinal anaesthesia. 
3. CSE anaesthesia in Obstetrics: 
         CSE was introduced in obstetrics as an attempt to reduce the adverse 
effects of traditional epidural techniques like prolonged labor, increased 
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need for oxytocin augmentation, and increased incidence of instrumental 
delivery. CSE is currently very popular in obstetric anaesthesia and 
analgesia 
[25 ]
. It is believed to improve maternal mobility during labor and 
compared to traditional epidural analgesia, provide more rapid onset of 
analgesia and better maternal satisfaction. In addition, CSE also allows 
prolongation of epidural analgesia or conversion to CSE.  
           In addition, CSE can be a good option in pregnant women with many 
serious medical conditions:   Reports of successful use of CSE anaesthesia 
or analgesia in patients with myasthenia gravis, idiopathic hypertrophic sub-
aortic stenosis, mitral stenosis, dilated cardiomyopathy, Guillain-Barre 
syndrome, Laron syndrome, tetralogy of Fallot, Liddle's syndrome, 
Wegener's granulomatosis with subglottic stenosis have been reported. 
   4. CSE anaesthesia in paediatrics: 
A study showed that CSE anesthesia could be considered as an 
effective anesthetic and analgesic technique for elective major upper 
abdominal surgery in awake or sedated neonates and infants 
[26]
. 
COMPLICATIONS AND CONCERNS OF CSE TECHNIQUE: 
        1. Spinal component failure. 
        2. Spinal migration of catheter or sub arachnoid administration of  
epidural drugs 
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       3. Neurological trauma 
                    -   Needle trauma 
                    -  Metal toxicity  
                    -  Infection        
     4. Hypotension 
     5. Post Dural Puncture Headache. 
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                         EPIDURAL VOLUME EXPANSION 
Epidural  Volume  Expansion or extension( EVE) is  a modification 
of  the conventional Combined Spinal Anaesthesia  where subarachnoid 
block is  induced with a small-dose intrathecal local anaesthetic with or 
without opioid  to produce a limited block, which can be extended or 
expanded with epidural top-ups of local anaesthetic or saline. 
 It is well recognised that any alterations in the contents of the spinal 
canal influences the spread of local anaesthetics.  Since the compliance 
within the spinal canal is dependent on the balance between CSF volume 
and blood volume the injection of local anaesthetic or normal saline into the 
epidural space will produce initial shift of these components. 
During conventional CSE anaesthesia, injecting local anaesthetic into 
the epidural space after spinal anaesthesia reportedly speeds the onset and 
raise of the subarachnoid block. Blumgart et al 
[4]
 through their study 
demonstrated that the mechanism of this extension is larlely a “Volume 
effect” than the “local anaesthetic effect” as such. Later normal saline was 
used  to produce this same volume effect .Tetsuo Takiguchi et al 
[7]
  
evaluated the effect of epidural saline on the block profile during CSE 
anaesthesia clinically and also myelographically. They demonstrated radio 
graphically that the level of the contrast in the subarachnoid space increased 
with sequential injection of normal saline into the epidural space. Maximal 
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extension was seen during the first injection. The diameter of the 
subarachnoid space was found to diminish with saline injection. The 
diameter decreased to 40% after the first epidural injection of saline and to 
25% after the second injection. This  ‘volume effect’ produced by the 
epidurally administered normal saline  compresses the subarachnoid space 
resulting in „squeezing’ of cerebrospinal fluid and more extensive spread of 
spinal local anaesthetic. 
          This volume effect appears to be time-dependent. Beyond 30 minutes 
or after two-segment regression, epidural top-up of saline would have no 
effect on block extension and may even accelerate regression of the spinal 
anaesthetic.                                                
           Epidural Volume Expansion has ceiling effect. A ceiling effect was  
demonstrated after 15 ml of saline injection
[10 ]
. 
 Advantages of epidural volume expansion: 
    1. Early onset of the block  
    2. Higher level of sensory blockade
 [ 8,9]
 
    3. Reducing in local anaesthetic dose
 [9] 
   4. Faster motor recovery
[9]
 
                    
They have similar disadvantages as for Combined Spinal 
Anaesthesia. 
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                    PHARMACOLOGY OF  BUPIVACAINE  
BUPIVACAINE: 
               Bupivacaine is an amino amide local anaesthetic characterised as 
pipecoloxylidides. Eoaf Ekentem and his colleagues of  Sweden  
synthesized it in 1957, later in 1963,  L . J. Telivuo used  it  clinically for 
the first time. 
            Bupivacaine is (RS)-1-butyl-N-(2, 6-dimethylphenyl) Piperidine-2-
Carboxamide monochloride monohydrate.  Addition of butyl group to the 
piperidine nitrogen of Mepivacaine results in Bupivacaine.  It is a chiral 
drug because of the presence of asymmetric carbon atom and is available as 
a racemic mixture.  It has the following structural formula:   
 
                                BUPIVACAINE 
     It is a very stable compound with a molecular mass of 288.43g/mol. 
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Preparations  available: 
Ampoule-0.5%  Bupivacaine Hydrochloride, 4cc with dextrose.   
               -0.5% Bupivacaine Hydrochloride 20cc isobaric. 
Vials-0.25% and 0.5% Bupivacaine hydrochloride 20 cc. 
USES: 
      1. Infiltration Anaesthesia 
      2. Peripheral nerve blocks 
      3. Sub Arachnoid Anaesthesia 
      4. Epidural Anaesthesia 
      5. Caudal Anaesthesia 
 Pharmacological Properties: 
    PKa     :      8.1 
    Protien binding :      95%    
    Lipid Solubility :      28 % 
    Volume of distribution        :       73 liters 
    Onset time :       5-7 min  
    Clearance of Drug from plasma:  0.147 lit/min 
    Elimination Half life     :        3.5 hours (adults) 
                                                         8.1 hours (neonates) 
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PHARMACODYNAMICS: 
          Bupivacaine binds to the ion selective sodium channels in nerve 
membrane and blocks sodium influx into nerve cells, which prevents 
depolarisation. Since pain transmitting fibers are unmyelinated or lighty 
myelinated, it can diffuse easily into them then the heavily myelinated nerve 
fibers like touch, proprioception etc. It also blocks Potassium channels 
which contribute to membrane potential depolarisation. 
            The order of loss of nerve function is as follows: 
        Pain> Temperature> Touch > Proprioception>Skeletal muscle tone. 
         It causes a decrease in cardiac output, by decreasing the sympathetic 
tone, heart rate and also venous return. 
      It also increases gastro intestinal tract motility. 
PHARMACOKINETICS: 
             Bupivacaine is a weak base with only 15% of drug existing in non 
ionised form at physiological PH.  
Absorption: 
            The systemic absorption   of bupivacaine is dependent on various 
factors like, the total dose and concentration of the drug, the route of 
administration, the vascularity of the administration site, and the presence or 
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absence of epinephrine in the anaesthetic solution.  Because of its high lipid 
solubility it easily enters nerve and vascular tissue penetration.80-85 % of 
absorbed bupivacaine enters plasma. 
             It also crosses the placenta by passive diffusion.  But due to its high 
protein binding capacity of 95%, it has a low fetal/maternal ratio (0.2 to 
0.4).  
          After caudal, epidural, or peripheral nerve block its peak levels in the 
blood reached in 30 to 45 minutes. 
Distribution: 
 Bupivacaine has 2 phases of distribution: 
          Rapid distribution Phase (Alpha):  Initial distribution of drug to 
highly vascular regions. Half time is around 2.7 minutes. 
        Slow disappearance Phase (Beta):  Drugs redistributes and slowly 
equilibrates into less vascular tissues. Half time is around 28 minutes 
Metabolism 
                   Bupivacaine undergoes aromatic hydroxylation, N–dealkylation, 
amide hydrolysis and conjugation. The major metabolite of bupivacaine is 
2,6-pipecoloxylidine, which is mainly catalyzed via cytochrome P450 3A4. 
Alpha1 acid Glycoprotien is its important   binding site. After epidural or 
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intrathecal injection only N- dealkylated metabolite N-desbuylbupivacaine 
was measured in blood or urine. 
Elimination: 
            The total urinary excretion of Bupivacaine and its metabolites is 
>40% of the total anaesthetic dose.  Poor water solubility of unchanged drug 
limits its renal excretion. Only 6% of bupivacaine is excreted unchanged in 
urine.  
 Bupivacaine in pregnancy:      
                  Bupivacaine Hydrochloride is contraindicated for obstetrical 
paracervical block. Local anaesthetics rapidly cross the placenta.When used 
for epidural, caudal, or pudendal block, can cause varying degrees of 
maternal, fetal, and neonatal toxicity. Adverse reactions in the mother, fetus, 
and neonate involve alterations of the peripheral vascular tone, central 
nervous system and cardiac function. Maternal hypotension has resulted 
from regional anaesthesia. Local anaesthetics produce vasodilatation by 
blocking sympathetic nerves. 
ADVERSE EFFECTS: 
                    The principal side effects are due to excess plasma 
concentration of unbound drug, more likely due to inadvertent intravenous 
injection .Systemic exposure to excessive quantities of  Bupivacaine mainly 
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result in central nervous  system (CNS) and cardiovascular effects. Plasma 
concentration greater than 1.5 microgram/ml is associated with toxic effects. 
Safe therapeutic dose is less than 3 mg/kg body weight.  
1. Central Nervous System toxicity:  
                    CNS effects usually occur at lower blood plasma. Plasma 
concentration of 4.5-5.5 mcg/ml is associated with seizures. CNS effects 
may include initial CNS excitation characterised by nervousness, numbness 
around mouth, tinnitus, tremor, blurring of vision, seizures followed by 
depression causing drowsiness, loss of consciousness and respiratory 
depression. 
2. Cardio vascular System toxicity: 
                     Cardiovascular effects are mainly hypotension, bradycardia, 
dysrrhythmias, and/or cardiac arrest .The rate of recovery of bupivacaine 
induced atrio ventricular blocks is slower than that due to other local 
anaesthetics. 
Management of Local Anaesthetic toxicity Emergencies: 
           The first consideration is prevention, best accomplished by careful 
monitoring of vital signs and the patient‟s state of consciousness after each 
local anaesthetic injection. 
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           1. Establishment and maintenance of a patent airway and effective 
assisted or controlled ventilation with 100% oxygen. 
           2. If necessary, use drugs to control the convulsions. A 50 mg to 100 
mg bolus intravenous injection of Succinylcholine will paralyze 
the patient. 5 to10 mg of diazepam or 50 to 100 mg of thiopental 
can also be used. 
           3. The adequacy of the circulation should be evaluated. Intravenous 
fluids, a vasopressor dictated by the clinical situation (such as 
ephedrine or epinephrine to enhance myocardial contractile force) 
should be used. The supine position in pregnant women at term 
causes aortocaval compression by the gravid uterus. During 
treatment of systemic toxicity, maternal hypotension or fetal 
bradycardia following regional block, the parturient should be 
maintained in the left lateral position if possible, or manual 
displacement of the uterus off the great vessels be accomplished. 
4. Start early CPR if cardiac arrest is noticed. 
5.  Intravenous Lipid emulsion: 20% lipid emulsion 1.5ml/kg rapidly 
followed by 0.25ml/kg/min for the next 10 minutes.  
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PHARMACOLOGY OF FENTANYL 
              Fentanyl is a potent, synthetic narcotic analgesic with a rapid onset 
and short duration of action. It is a strong agonist at the μ-opioid receptors. 
It is phenylpipeidine opioid of the 4-anilopiperidine series which is 
structurally related to Pethidine. Fentanyl was first synthesized by Paul 
Janssen in 1960. 
             Commercially it is formulated as a citrate, available as an aqueous 
solution. Each ml contains a base of 50 mcg of Fentanyl. 
Pharmacological properties: 
 
  
 
 
 
 
 
 
Molecular weight                                   528.29 
 pKa                                                        8.4 
% of unionised drug at Ph 7.4                8.5% 
Octanol/water partition 
coefficient             
        816 
Protien binding         80-85% 
Potency 80 times than Morphine 
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PHARMACODYNAMICS: 
     Analgesia: 
                Fentanyl acts on the mu receptors in the brain and spinal cord to 
produce an analgesic effect which is 80 times higher than that of Morphine. 
Intravenously administered Fentanyl provides effective analgesia at plasma 
concentrations of 0.6-3 ng/ml. 
   Cardiovascular System: 
                Fentanyl like other opioids (except Pethidine) causes bradycardia, 
which responds to intravenous Atropine. Peripheral vasodilatation is less 
compared to Morphine due to absence of histamine release. 
Respiratory System: 
              Fentanyl causes dose dependent respiratory depression by its 
depressant effect on the medullary respiratory centre. Plasma concentration 
of 0.2ng/ml is usually associated with respiratory depression. It is reversed 
by intravenous Nalaxone administration.        
 Central Nervous System: 
            It causes less sedation than equivalent dose of Morphine. Reduction 
in cerebral blood flow and cerebral metabolic requirement of O2 was found 
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to be decreased after intravenous doses of 10mcg/kg. Muscle rigidity might 
be reflection of catatonic state, pharmacological properties of opioids, due 
to enhancement of Dopamine biosynthesis in the caudate nucleus. 
Gastrointestinal Tract:  
           Gastric mobility decreases on Fentanyl administration. Nausea 
vomiting is due to increased intrabiliary pressure. Vomiting is also mediated 
by stimulation of the chemoreceptor trigger zone in the area postrema. 
Genito urinary system: 
             Like other opioids Fentanyl causes relaxation of the detrusor muscle 
and thus increases the urethral sphincter tone leading to urinary retention. 
This effect is more common seen during central neuraxial administration. 
PHARMACOKINETICS:  
          Fentanyl is highly lipophilic, producing a rapid onset of action and 
relatively short duration of action. After intravenous administration, it is 
rapidly distributed to highly perfused organs like brain. Peak action is seen 
within 5 minutes. Later it gets redistributed into inactive tissues. 
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Pharmacokinetic profile:      
Volume of distribution 335 liters 
Clearance 1530 ml/min 
Effect site equilibration time 6.8min 
Hepatic extraction ratio 0.8 
context sensitive half time 260 minutes 
Elimination half time  3.1-6.6 hours 
                
  Metabolism: 
           Fentanyl is biotransformed in the liver to inactive metabolites, 
primarily Norfentanyl and other hydroxylation products. Only 4-7% is 
excreted unchanged in urine. The clearance of Fentanyl is limited by hepatic 
blood flow. 
INTRATHECAL FENTANYL: 
                 Intrathecal route of administration of  Fentanyl is an established 
route for intra and post operative analgesia. 
               Fentanyl has the same baricity as CSF at room temperature. 
Addition to hyperbaric Lignocaine or Bupivacaine makes the solution 
hyperbaric. On intrathecal injection, Fentanyl mixes with CSF and attaches 
itself to opioid receptors in the spinal cord. Protein binding of drug in CSF 
is negligible and the concentration of opioid in CSF is only free drug 
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concentration. Once in the CSF, Fentanyl spreads rostrally. Because of the 
high affinity of Fentanyl with binding sites in the lipid rich spinal cord, only 
10% of the administered dose reaches cervical region.  
                 Diffusion into spinal cord and absorption into the blood removes 
it from the CSF since CSF dynamics does not provide any means of drug 
removal. 
Advantages of Fentanyl as an adjuvant in neuraxial blocks: 
                     Intrathecal Fentanyl is used as an adjuvant to local anaesthetics 
for perioperative anaesthesia and analgesia. Fentanyl administered 
intrathecally provides more intense blockade, at a lower dose requirement as 
compared to epidural or intravenous routes. 
SIDE EFFECTS OF INTRATHECAL OPIOIDS: 
   1. Pruritis.                
   2. Nausea and vomiting. 
   3. Urinary retention. 
   4. Depression of ventilation. 
   5. Sedation. 
   6. CNS excitation. 
   7. Neonatal morbidity. 
   8. Gastrointestinal dysfunction. 
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   9. Water retention. 
   10. Thermoregulatory dysfunction.  
            Side effects are relatively minor with fentanyl. A 30% incidence of 
urinary retention, respiratory depression, varying degree of prurtis and 
occasional episodes of nausea have been documented. 
          Other  modes of administration are intramuscular, intravenous, 
transdermal, transmucosal, intranasal and transpulmonary routes. 
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                                 ASSESSMENT OF PAIN 
            Reliable quantification of pain severity is important to assess the 
analgesic effect of a drug or any therapeutic interventions. Since pain is a 
subjective experience that is influenced by many factors like psychological, 
cultural variables, it is difficult to assess the intensity of pain. There are 
many scales available for assessing pain. Commonly used are:  
                          1. Visual Analogue Scale (VAS). 
                          2. Numerical rating scale. 
                          3 .Faces rating scale. 
                          4.  McGill Pain Questionnaire (MPQ).  
                The VAS is an efficient, simple and minimally intrusive method 
which gives subjective measure of pain
[ 27] 
. It consists of a 10cm line with 
two end-points indicating „no pain‟ and „worst pain imaginable‟.  
 
NO PAIN  100mm   WORST PAIN 
VISUAL ANALOGUE SCALE 
40 
 
          Patients are asked to rate their pain by marking on the line 
corresponding to their current level of pain. The distance along the line from 
the „no pain‟ marker is then measured with a ruler giving a pain score out of 
10.  
 ADVANTAGES OF VAS: 
      1. Simple and easy to use.  
      2. Valid in a wide range of settings. 
      3. Versatile. 
      4. Straightforward to interpret 
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                        ASSESSMENT OF MOTOR BLOCK 
            Assessment of motor blockade is an integral part of any anaesthetic 
procedure. During neuraxial blockades assessing the motor blockade of 
lower limbs provide information about the intensity of the block. The 
commonest method used for assessing the motor blockade is Bromage 
score. 
 Bromage score
[ 28]
: 
        
 Many modifications of Bromage scoring have been described.     
GRADE DEFINITION 
0 No motor block 
1 Inability to raise extended leg; able to move knees and feet 
2 
Inability to raise extended leg and move knee; able to move 
feet 
3 Complete block of motor limb 
Grade Criteria Degree of block 
I Free movement of legs and feet Nil (0%) 
II Just able to flex knees with free movement of feet Partial (33%) 
III Unable to flex knees, but with free movement of feet Almost complete (66%) 
IV Unable to move legs or feet Complete (100%) 
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    Another modification of  Bromage score by Breen et al, which is also 
used commonly.         
Modified Bromage score as used by Breen et al
[ 29] 
 
       
 
 
 
 
 
 
 
 
Score Criteria  
 1 Complete block (unable to move feet or knees)  
 2 Almost complete block (able to move feet only)  
 3 Partial block (just able to move knees)  
 4 Detectable weakness of hip flexion while supine (full flexion of knees)  
 5 No detectable weakness of hip flexion while supine  
 6 Able to perform partial knee bend  
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                                     REVIEW OF LITERATURE 
 
                           1. C.H. Blumgart et al
[4]
 (1992)  examined the effect of 
epidural injection of 0.5% bupivacaine or normal saline on  the progression 
of subarachnoid block in 28 pregnant patients undergoing caesarean section. 
Sub arachnoid block was established in all patients. Nine patients received 
10 ml of epidural saline, another nine recieved 10 ml of 0.5% Bupivacaine 
and control group did not receive EVE following intrathecal injection. 
Sensory levels were recorded every 5 minutes. The blockade level was 
found to be higher and faster in patients who received EVE than the control 
group. Incidence of adverse effects was similar in all 3 groups. 
            They stated that the mechanism of extension of subarachnoid block 
by Epidural injection of local anaesthetic was largely a volume effect, and 
SAB may be extended as effectively with extradural injection of normal 
saline as with Bupivacaine. And they questioned if subarachnoid block be 
extended when saline was injected after 20 minutes of intrathecal 
injection. 
                             2.Mardirosoff  et al
[5]
 (1998), conducted a study to 
evaluate the time dependency of the volume effect and the local anaesthetic 
effect on the spinal block extension. They   performed there study in two 
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parts. 30 patients were randomized in each study. CSE anaesthesia was 
performed in sitting position in all groups. The patients in the first study 
received 15 mg of hyperbaric 0.5% Bupivacaine into the intrathecal space 
and were placed supine 2 minutes after spinal injection. They received 10 
ml epidural saline either 5 minutes (group A) after or 20 minutes(group B) 
after intrathecal injection .These two groups were  compared to a control 
group (group C), which did not receive any top ups. The patients in the 
second study received 12.5 mg of hyperbaric bupivacaine into intrathecal 
space and were placed supine after 5 minutes. After 7 minutes of intrathecal 
injection they received either10 mL saline (group D) or 10 ml Bupivacaine 
(group E) or nothing (group F). After analysis, in the first portion of their 
study in group A, the maximum sensory block levels were significantly 
higher (P < .05) as compared to groups B and C. In the second portion of 
the study, sensory block levels were comparable at all times in all the three 
groups.  
         In Conclusion they stated that during CSE technique with the use of 
hyperbaric bupivacaine, the volume effect was time dependent and seen 
when epidural top up was done soon after spinal injection. This effect was 
abolished if patients are left seated for more than 5 minutes following 
intrathecal injection. 
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                    3. Walter J. Trautman et al
[6]
 (1997) conducted a study 
to test the efficacy of normal saline as an epidural top up to prolong the 
SAB during CSE anaesthesia after two segment regression. Eight 
volunteers received three separate CSEAs with 50 mg of intrathecal 
Lignocaine. After two segment regression, each of the volunteer 
received either 10 ml saline, 10 ml 1.5% Lignocaine, or 0.5 ml saline 
(control sham). Sensory block was assessed by pinprick and tolerance 
to Transcutaneous Electrical Stimulation (TES). Motor strength was 
assessed with isometric force dynamometry. 
                        They observed that epidural lignocaine prolonged the 
sensory block by an average of 28 minutes compared with saline and 
control sham injection. Epidural saline decreased the duration of 
tolerance to TES at knee or ankle. 
       They concluded that 10 ml of epidural saline, if administered after 
two segment regression, is an ineffective top up and may decrease 
duration of initial SAB during CSE anaesthesia.    
                     4. Tetsuo Takiguchi et al[7]  (1997) studied the effect of 
epidural saline on analgesic level during CSE anaesthesia clinically and 
myelographically. Twenty patients who were undergoing elective surgery 
under   CSE anaesthesia  in whom adequate sensory levels were not 
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achieved even after 10 minutes of spinal anaesthesia at the L4-5 interspace 
were allotted into 2 groups.10 ml of saline was given epidurally in study 
group and the control group received nothing in epidural space. They found 
significantly higher sensory levels in saline group than the control group.  
                Also to evaluate the effect of epidural saline myelographically, 2 
healthy volunteers were given 7 ml of contrast medium iohexol(specific 
gravity 1.268-1.296) into  L4-5 intrathecal space. After radiographic 
confirmation, 5 ml of saline was injected incrementally into epidural space 
to a total volume of 20ml. The level of contrast agent was assessed 
fluoroscopically. There was a rise in the level following every 5 ml 
injection. The diameter of the subarachnoid space also diminished 40% after 
first injection and 25% after second injection. 
         They concluded that a lumbar epidural saline is useful for increasing 
the anaesthetic level 10 minutes after spinal anaesthesia, which is probably 
the result of a volume effect. 
                      5.   John Chirayanth and Radhika Dhanpal
[8 ]
 (2002) evaluated 
the effect of  epidural top up in CSE in 60 patients who underwent below 
umbilicus surgery. Three  groups of  20 patients each were selected. SAB 
was established in all the groups with 2.5 ml of 0.5% hyperbaric 
Bupivacaine. Group 1 recieved 10 ml of 0.5% Bupivacaine as epidural top 
up.  Group 2 recieved 10ml of normal saline as epidural top up. Group 3 did 
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not receive any epidural top us and acted as control. The blocks were 
performed in either sitting or lateral position using double segment CSE 
technique. Maximum level of sensory block, motor block, time for block 
regression were studied in all 3 groups. Their study demonstrated that the 
maximal sensory blockade levels were higher in patients who received 
bupivacaine as epidural top up  than in patients  who received saline ,which 
inturn was higher than the group which did not receive any epidural top ups. 
This study also showed that lateral position results in a greater spread of the 
intrathecal drug than the sitting position. An additional observation was that 
the level worn off faster in the group who received normal saline as epidural 
top up.    
          This study concluded that  deposition of local anaesthetic in the 
epidural space increased the sensory level of spread  of SAB and performing 
this block in lateral position accentuated this spread.  And also epidural top 
ups with normal saline leads to faster recovery of the block. 
            6. Lew E et al 
[9]
, (2004) conducted a double blinded, prospective 
study in 60 parturients, scheduled to undergo elective caesarean section 
under Combined Spinal Epidural anaesthesia. They compared the sensory 
and motor block profile and also the hemodynamic stability of Epidural 
Volume Expansion ( n=30) with single shot spinal anaesthesia (n=30). 
Patients in EVE group received 5 mg of 0.5% hyperbaric Bupivacaine 
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intrathecally followed by 6 ml of 0.9% saline in the epidural space, and 
patients in spinal anaesthesia group received only 9 mg of 0.5% hyperbaric 
Bupivacaine intrathecally. 10 mcg of Fentanyl was added as an adjuvant to 
spinal bupivacaine in both the groups. Hemodynamic parameters, sensory 
block level, Modified Bromage score were recorded. Time required for 
sensory regression to T10 dermatome, first request of post operative 
analgesia, and complete motor recovery was noted. It took 73 ± 33 minutes 
for complete motor recovery in EVE group and 136 ± 32 minutes in spinal 
anaesthesia group, which was statistically significant. They did not observe 
any significant difference in hemodynamic parameters. 
It was concluded that Combined Spinal Epidural Anaesthesia with 
EVE provides adequate anaesthesia required for caesarean sections with 
only 55% of bupivacaine dose and also allows faster motor recovery of the 
lower limbs. They suggested that CSE with EVE could be a novel 
alternative to conventional dose single shot spinal anaesthesia for caesarean 
sections 
                7.Dognci et al
[10]
,(2010) conducted a study in 75 patients undergoing 
below umbilicus surgery with an aim to evaluate the block characteristics 
following epidural saline after sub arachnoid blockade and to find whether 
EVE has a ceiling effect. Patients were assigned into 5 groups. All patients 
received 10 mg of spinal isobaric  bupivacane. One of the groups did not 
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receive any epidural top up and acted as control group. Other 4 groups 
received 5, 10, 15 or 20 ml saline as epidural top ups after 5 minutes of 
intrathecal injection. Motor and sensory block was assessed every minute. 
All the EVE groups showed higher block level than control group, but no 
significant difference was found between the 4 EVE groups. Duration of 
analgesia was higher in 15 ml saline group. 
            They concluded that the duration of analgesia was longer with 15ml 
or more of epidural saline and ceiling effect of maximum analgesic level 
was obtained with as low as 5 ml of additional saline. 
                8. Mahmut Deniz et al
[11]
, (2010), investigated the influence of 
epidural saline as a top up blockade characteristics in CSE anaesthesia in 50 
patients undergoing Trans Urethral Resection of  Prostrate[TURP]. 
Subarachnoid block was performed with 10 mg of heavy Bupivacaine in all 
patients. 25 of them received EVE with 5 ml epidural saline. The sensory, 
motor blockade profile, hemodynamic variables were recorded at 5 minutes 
interval. The sensory levels were higher in patients with EVE. The time for 
sensory regression to S1 and complete motor recovery were same in both 
the groups. Hemodynamic stability was not significantly different.  
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           They concluded that saline injection as epidural top up provides an 
increased sensory blockade without changing the hemodynamic data or 
sensory and motor block profile. 
          9. Asha Tyagi et al
[ 12]
, 2011 compared the effect of change in 
position during block performance, on the epidural volume expansion in 56 
patients undergoing caesarean section. They were allotted into 4 groups. All 
Groups received 9mg of hyperbaric Bupivacaine and 10 mcg of Fentanyl 
intrathecally.  Group S received intratecal injection in sitting position, group 
L in lateral position. Group LE received intrathecal injection in lateral 
position followed by 5ml of saline epidurally, whereas group SE received 
intrathecal injection and 5ml of epidural saline in sitting position. The 
maximum sensory block attained was found to be highest in patients who 
received EVE in lateral position. No significant difference was noted in time 
to achieve maximum sensory level, maximum Bromage score, and time for 
complete motor block regression, incidence of hypotension or perioperative 
complications. 
        This study showed that if EVE technique is used with an intension of 
increasing the level of spinal block, the CSE should be performed in lateral 
position rather than in sitting position. 
         10. C.Loubert et al
[13]
, (2011) investigated the effect of EVE on spinal 
blockade in patients undergoing caesarean section with CSE technique. 90 
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patients were randomly assigned into 3 groups. Group B7.5 received 7.5 mg 
hyperbaric Bupivacane intrathecally, group B7.5 EVE received 7.5 mg 
intrathecal  bupivacaine followed by EVE with 5 ml saline and group B10 
recieved 10mg of intrathecal  hyperbaric Bupivacaine alone. All patients 
received 25 mcg of Fentanyl as adjuvant. They assessed the height of the 
sensory block every 5 minutes. The mean sensory levels were found to 
increase significantly from 5 minutes to 15 minutes of intra thecal injection 
in all the groups.This study did not demonstrate any significant difference in 
median sensory block heights between the groups. They observed lesser 
motor blockade in group B7.5 EVE than in B10 group. Hemodynamic 
parameters were similar in both the groups.  
          In conclusion their study did not show any benefit of using EVE with 
5 ml of saline as part of CSE technique in patients undergoing caesarean 
section. 
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METHODOLOGY 
                   This single centred, prospective, randomized, double blinded 
study was conducted at Thanjavur Medical College, Thanjavur. After 
obtaining the institutional Ethical committee approval, 60 patients who got 
admitted in the obstetrics ward of Raja Mirasrudhar Hospital scheduled for 
elective caesarean section under regional anaesthesia were included in the 
study. A written informed consent was obtained from all the patients. 
  Inclusion criteria: 
        a.     ASA Physical Status I and II. 
        b.     Age between 19-35 years.   
        c.     Body weight between 50-95 kgs. 
        d.     Height   150-170 centimetres.
 
        e.      Singleton uncomplicated Pregnancies. 
        f.     Gestational age more than 37 weeks. 
  Exclusion criteria: 
         a.    Patients with contraindication to regional anaesthesia like bleeding 
diathesis, spine deformity, local site infection 
      b.   Hypertensive disorders 
      c.     Peripartum hemorrhagic conditions 
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 All the patients were randomly allocated to one of the two groups 
namely Group S and Group E using sealed envelope method. 
Group S: 30 patients received 9 mg of 0.5% hyperbaric Bupivacaine(1.8ml) 
and 10 microgram of Fentanyl(0.2ml) [1.8ml+0.2ml=2ml] as single shot 
spinal anaesthesia.  
    Group E: 30 patients received 5mg of 0.5% hyperbaric bupivacaine 
(1ml) and 10 microgram of Fentanyl (0.2 ml) into intrathecal space [1.0 
ml+0.2ml=1.2ml] followed by 6 ml of saline epidurally. 
MATERIALS: 
      a. Sterile tray, swabs and towels, sponge holding forceps. 
      b. Sterile disposable 5 ml and 10 ml syringes. 
      c.   Local anaesthetic drug for skin infiltration: 2% lignocaine 2-3ml. 
      d. 25G Quincke‟s spinal needle( Spinocan, Braun, Germany). 
      e. 17G Tuohy needle(Vygon, Ecouen, France) 
      f. 19G Epidural catheter(Vygon, Ecouen, France) 
      g. Equipments and drugs for resuscitation 
  h. Equipments and drugs for conversion to general anaesthesia in case      
         of block failure.  
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METHODS: 
  Pre Anaesthetic Assessment: 
              Preoperative evaluation that included detailed history, physical 
examination and airway assessment was done and documented. Base line 
investigations like blood grouping/typing, haemoglobin, bleeding/clotting 
time, blood sugar, renal function test, urine routine, ECG was done. 
             Visual Analogue Score consisting of 100mm line with 0 = no pain 
and 10 =worst pain was explained to all the patients. 
Pre operative preparation: 
             All patients were kept fasting for 6 hr. On arrival of patient in the 
pre operative room, patients were given reassurance about the procedure and 
surgery. Baseline vital parameters were recorded. A new intravenous access 
was established using 18G. Injection Ranitidine 50 mg
 
and injection 
Metaclopramide 10 mg was given intravenously 30 minutes before surgery. 
              In the operating room, monitors like pulse oximeter, non-invasive 
blood pressure and lead II electrocardiography were connected and required 
interval for recording been set.10ml/kg of Ringer Lactate was infused as 
preloading 10 minutes prior to regional anaesthesia. 
             Regional Anaesthesia was performed in right lateral position in all 
the patients. 
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               In all the 60 patients, with aseptic precautions local infiltration 
with 2% lignocaine was done both in third and fourth lumbar spaces. 
Epidural space was identified by loss of resistance to air at L3-L4 space 
using a 17 G Touhy needle. A multiorificed 19G epidural catheter was 
placed 4 cms rostrally in the space. 
Single Shot Spinal Anaesthesia Group (Group S): 
             After placing the epidural catheter, 25G Quincke‟s needle was 
introduced into fourth lumbar intervertebral space. On confirming free flow 
of CSF, total volume of 2ml of drug ( 9 mg of 0.5% hyperbaric bupivacaine 
with 10 mcg of Fentanyl ) was interjected over 10 seconds. Patients were 
positioned supine with wedged pillow under right hip. 
           The point at which the spinal needle was removed from the patient 
marked the completion of spinal anaesthesia. 
Epidural Volume Expansion Group (Group E): 
            After placing the epidural catheter a 25 G Quincke‟ needle was 
introduced into L4-L5 intervertebral space and after confirming free flow of 
CSF 1.2 ml of the drug (5 mg of 0.5% hyperbaric Bupivacaine and 10 
microgram of Fentanyl) was injected intrathecally over 10 seconds.
  
patients 
were positioned  supine with a wedge pillow under right hip. 
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            6 ml of sterile normal saline was injected through epidural catheter 
within 3 minutes of completion of intrathecal injection. 
           The completion of saline injection marked the completion of EVE. 
Intra operative monitoring:   
            Patients pulse rates, MAP, SpO2 were recorded every 2.5 minutes
 
for the next 30 minutes and every 10 minutes for the following next 30 
minutes and then every 30 minutes in recovery room till complete motor 
recovery.         
Block evaluation:   
          The point of completion of each regional technique was recorded as 
Time ‘0’   [T0]    
          Block evaluation was done every 2.5 minutes till 3 consecutive 
readings remained the same.   
Sensory block evaluation:         
               Patient was explained about the pinpricks by a blunted needle and 
reassured. The sensory blockade was assessed by loss of pain for pin prick 
to 25 G blunted needle checked bilaterally in the midclavicular line. 
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Motor block evaluation: 
            The motor blockade was assessed using Modified Bromage score. 
Score 0 – Able to move hip, knee and ankle. 
Score 1 – Unable to move hip, able to move knee and ankle. 
Score 2-   Unable to move hip and knee, able to move ankle. 
Score3 – Unable to move hip, knee and ankle. 
 The following block characteristics were recorded beginning from Time „0‟  
1. SMAX    :  Maximum sensory block achieved. 
2. TSMAX   :   Time when SMAX was first achieved. 
3. Treg-10   :  Time when block regressed to T10 dermatome level 
4. TPAIN    :  Time for first complain of pain. 
5. MMAX  :   Maximum motor block achieved. 
6. TM.MAX :  Time when MMAX was achieved.   
      7. TM0     :  Time for complete motor recovery 
                        [modified Bromage score0]             
              Surgery was allowed to proceed when sensory block level of T4 
was at achieved.   
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             Visual Analogue Score was assessed at the point of surgical 
incision.VAS would be reassessed in patients intra operatively if they 
complain of pain, and if found to be higher than 3, epidural top ups of 2% 
lignocaine 3 ml would be given and repeated if VAS is still high. If VAS 
remains persistently more than 3 then general anaesthesia would be given to 
the patient.     
            Oxytocin 10U was given as infusion in both the groups after the 
delivery.     
             Hypotension  ( defined as systolic blood pressure of < 100mm Hg 
or a reduction in MAP of more than 20% from base line )was planned to 
treat by  intravenous boluses 6 mg of Ephedrine. 
             Bradycardia( defined as heart rate of less than 60 beats /minute) 
was planned to be treated with intravenous Atropine 0.6 mg.  
             Nausea or Vomiting was planned to be treated with rescue 
antiemetic drugs using intra venous ondansetron 4–8 mg or intra venous 
metaclopramide 10 mg.  
            Shivering was planned to be treated with IV tramadol 1mg/kg after 
delivery of the baby.  
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           APGAR score would be assessed at 1 min and 5 min. 
            Degree of Maternal satisfaction would be graded as follows on  4 
point scale. 
             4- Excellent 
             3-Good 
             2-Satisfactory 
             1-Poor 
  In the post operative period, monitoring was continued in all 
patients. 
 Post operative analgesia was provided by epidural top ups of 0.125% 
Bupivacaine.  
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OBSERVATIONS AND RESULTS 
                   This study comprised of two groups consisting of 30 patients 
each. The patients in group S received 9 mg of 0.5% hyperbaric 
Bupivacaine with Fentanyl as single shot spinal anaesthesia. The patients in 
group E received 5 mg of 0.5% Bupivacaine with Fentanyl intrathecally 
followed by Epidural Volume Expansion with 6 ml of normal saline.  
           All the 60 patients completed the study. The collected data was 
recorded in a master chart. Data analysis was done with the Epidemiological 
Information package using a computer. Chi square test was used to test the 
significance of qualitative variables.      
                 After inter group analysis data was presented as range, mean and 
standard deviation. The probability value „p‟ of less than 0.05 was 
considered statistically significant.  
               Demographic data like age, height and weight were comparable 
between the two groups. 
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AGE: 
                   Age distribution in group S was from 20 to 32 years. In group E, 
was between 19 and 32 years. „p‟ value was statistically insignificant. 
The results are as shown in Table1/ Figure 1: 
Table – 1    Age distribution in years 
       MEAN  SD              „p‟ 
      GROUP S      26.13  3.35          0.223 
     Not significant       GROUP E      25.10  3.14 
 
Figure  9      - AGE DISTRIBUTION IN YEARS 
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HEIGHT: 
               The mean height in group S was 156.13 cms. In group E mean 
height was 154.67 cms.„p‟value was  insignificant. 
Table - 2 Height distribution (in centimetres) 
 MEAN  SD „p‟ 
GROUP S 156.13  3.44 
0.173 
Not  significant 
GROUP E 154.67  4.69 
 
WEIGHT:  
              Group S had a mean weight of 66.37 Kgs. Group E had 67.70 Kgs. 
„p‟ was 0.572 which was insignificant. 
Table – 3 Weight distribution (in kilograms) 
 MEAN  SD „p‟ 
GROUP S 66.37  8.66 
0.57 
Not significant 
GROUP E 67.70  9.47 
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DURATION OF SURGERY:  
                      The mean duration of surgery in group S was 51.33minutes 
whereas in group E was 53.0 minutes. „p‟ value was statistically 
insignificant. 
Table -4 Duration of surgery (in minutes) 
      MEAN  SD             „p‟ 
      GROUP S      51.33  6.81           0.414 
     Not significant 
      GROUP E      53.00  8.77 
 
Figure 10    -DURATION OF SURGERY IN MINUTES 
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MAXIMUM SENSORY BLOCK( SMAX): 
            The maximum sensory blocade level achieved in group S was            
T3.8  1.28 minutes and in group E was T3.43  1.22 minutes. ‟p‟value was 
not significant. 
Table – 5 Maximum sensory levels achieved 
      MEAN  SD              „p‟ 
      GROUP S        T3.8  1.28              0.185 
         Not significant  
      GROUP E        T3.43  1.22 
 
TIME FOR MAXIMUM SENSORY BLOCKADE ( TS MAX): 
                The time required for maximum sensory level blockade in group S 
was 5.67 minutes. In group E it was 6.08 minutes. „p‟  value was 
statistically insignificant.  
Table – 6 Time required for maximum sensory blockade (in minutes) 
      MEAN  SD           „p‟ 
      GROUP S        5.67  1.72             0.350 
      Not significant 
      GROUP E        6.08  1.60 
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TIME FOR SENSORY LEVEL REGRESSION TO T10 (TREG-10): 
            The time required for the sensory level regression to 10 th 
dermatome in group S was 134.3minutes, whereas in group E 108.50 
minutes. „p‟ value was 0.000 which was statistically significant. 
Table – 7   Time for sensory level regression to T 10(in minutes) 
       MEAN  SD                    „p‟ 
      GROUP S       134.33  23.6                0.000 
           Significant  
      GROUP E      108.50  17.13  
 
Figure – 11 
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TIME FOR FIRST RESCUE ANALGESIA ( TPAIN): 
       The time at first request of analgesia in group S was 164.33 minutes and 
in group E 130.67 minutes. „p‟ value of 0.000 which is statistically 
significant was obtained. 
Table - 5 Time for first request of rescue analgesia 
      MEAN  SD              „p‟ 
      GROUP S       164.33  24.02              0.000 
       Significant 
      GROUP E       130.67   15.01  
 
Figure – 12: 
 
67 
 
 
MAXIMUM MOTOR BLOCK - BROMAGE SCORE ( MMAX): 
              The maximum Bromage score attained in group was2.9 and in 
group E  was 1.93. „p‟ value was 0.00 which is statistically significant. 
Table – 9     Maximum Bromage score 
      MEAN  SD           „p‟ 
      GROUP S        2.9  0.30             0.000 
      Significant  
      GROUP E       1.93  0.450 
 
Figure – 13: 
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TIME FOR MAXIMUM MOTOR BLOCKADE(TM.MAX): 
                The maximum motor blockade was attained after 7.25 minutes in 
group S whereas it was after 8.33 minutes in group E.‟p‟ value was 0.014 
which was  statistically significant was seen.  
Table – 10 Time for  maximum motor blockade( in minutes) 
     MEAN SD                  „P‟ 
GROUP S    7.251.78              0.014 
        Significant GROUP E    8.331.51 
 
Figure -14: 
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TIME FOR COMPLETE MOTOR REGRESSION (TM0): 
          The time required for complete motor regression in group S was 
183.0   23.21minutes, in group E was 79.50  17.38. ‟p ‟ value was 0.000 
which is statistically significant. 
Table – 11 Time for complete motor regression(TM0) 
      MEAN  SD           „p‟ 
      GROUP S          183  23.21         0.000 
     Significant       GROUP E         79.50  17.38 
 
MEAN ARTERIAL BLOOD PRESSURE: 
Table  - 12  Mean Arterial Blood Pressure( in mm Hg) 
INTERVALS 
IN MINUTES 
GROUP S 
MEAN  SD 
GROUP E 
MEAN  SD 
 
‘p’ 
0 86.10  8.25 82.9  9.23 0.16 
2.5 77.86.73 78.8615.72 0.34 
5 72.38.09 70.4310.16 0.433 
7.5 70.78.24 69.710.85 0.689 
10 67.58.09 70.938.31 0.521 
12.5 65.669.17 73.910.8 0.004 
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15 65.99.12 69.266.23 0.001 
17.5 65.69.17 69.87.08 0.05 
20 66.069.04 71.36.13 0.01 
22.5 71.2310.64 71.065.14 0.65 
25 70.367.91 72.45.05 0.45 
27.5 73.338.71 73.865.469 0.73 
30 69.39.28 74.15.568 0.08 
40 74.69.34 75.55.923 0.67 
50 74.17.54 74.95.625 0.78 
60 71.266.54 75.26.44 0.69 
75 73.868.30 75.76.54 0.71 
90 75.468.06 77.77.11 0.66 
105 74.338.05 75.95.97 0.67 
120 79.337.59 77.35.77 0.49 
 
Figure – 15 
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VISUAL ANALOGUE SCORE (VAS): 
            The VAS was 0.17 in group S and 0.00 in group E. The p value was 
statistically insignificant. 
Table - 13   Visual Analogue Score 
      MEAN  SD           „p‟ 
      GROUP S       0.17  0.913             0.321 
       Not significant       GROUP E     0.00  0.0 
 
APGAR SCORE: 
           APGAR score at 1 minute was 9.07 and 8.77 in group S and group E 
respectively. At 5 th minute was 9.73 in both the groups.‟p‟value was 
insignificant at both intervals. 
Table – 14  APGAR scores 
            MEAN  SD   
          „p‟ 
  
 1 minute 5 minute 
GROUP S 9.07  0.74 9.73  0.45 
0.107 ( > 0.05) 
 
GROUP E 8.77  0.679 9.73  0.45 1.0      ( >0.05) 
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TOTAL EPHEDRINE REQUIRED: 
               The total dose of Ephedrine required in group S was 15.8  
6.59mg  9.80  6.2 mg in group E. „p‟ value was 0.000  which was 
statistically significant. 
Table – 15 Total Ephedrine requirements (in milligrams) 
      MEAN  SD           „p‟ 
      GROUP S      15.8  6.59      0.001 
   Significant  
      GROUP E      9.8  6.2 
 
Figure – 16 
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ADVERSE EFFECT: 
         27 of 30(90%) in group S and 25of 30( 83.3%) in group E  developed 
hypotension. Shivering was seen in one patient in both the groups. One 
patient in group E developed pruritis. „p‟value was insignificant in all the 
groups. 
Table – 16 Adverse effects 
ADVERSE 
EFFECTS 
GROUP 
Statistical         
inference 
GROUP S GROUP E 
Hypotension 27 (90%) 25(83.3%) X
2
 = 2.744 
„p‟ 0.433   not         
significant 
Pruritis 0 1(3.3%) 
Shivering 1(3.3%) 1(3.3%) 
 
MATERNAL SATISFACTION SCORES: 
              Mean maternal satisfication score in group S was 2.73 and 3.0 in 
group E.‟p‟ value was insignificant. 
                                   Table -17 Maternal satisfaction scores 
      MEAN  SD           „p‟ 
      GROUP S         2.73  0.67            0.321 
   Not significant       GROUP E         3.0  0.82 
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DISCUSSION 
   Caesarean sections accounts for more than 30% of all births and is a 
common procedure performed worldwide. Providing anaesthesia to the 
parturient is a dynamic and multistep process which demands extra 
responsibility of maintaining both maternal and fetal physiology. 
  Overall, neuraxial techniques are prefered method for caesarean 
deliveries. Specific benefits and risks of each technique dictate the eventual 
choice. In this study it has been attempted to compare two different 
neuraxial techniques, conventional dose spinal anaesthesia and Combined 
Spinal Epidural Anaesthesia with EVE in respect to their sensory, motor 
block profile and hemodynamic stability in 60 patients undergoing 
caesarean sections.  
Collected data was analysed using appropriate tests. A „p‟value of 
<0.05 was taken as statistically significant. 
Demographic data including age, weight and height were analysed 
using students t-test and difference was not statistically significant [Table 1, 
2, 3 Figure1]. These results were similar to previous studies
 [ 9][12]
. 
The duration of surgery in group S was 51.33  6.81 minutes and 53.0 
 8.77 in group E. The difference was statistically insignificant. 
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Marc Van de Velde et al
 [36]
 and Asha Tyagi et al
 [12 ]
 preloaded their 
patients with 10ml/kg of Ringer Lactate just prior to surgery, which has 
been followed in this study.   
All the patients were premedicated with 50mg of Ranitidine and 
10mg of Metaclopramide intravenously 30 minutes before surgery as anti 
aspiration measures in accordance with Stuart et al
 [30 ]
 recommendations. 
Dyer RA, Joubert IA
 [3]
 described less than 8mg of Bupivacane as 
„low dose’ and more than 8mg as „Conventional dose‟ for intrathecal 
injections in pregnant patients. In our institution it is a routine practice to 
use 9mg of 0.5% hyperbaric Bupivacaine with Fentanyl for single shot 
spinal anaesthesia during caesarean sections. Lew et al
 [9 ] 
used 9 mg of 
intrathecal Bupivacaine with 10 mcg of Fentanyl intrathecally in their 
control group. In this study also control group received 9mg of Bupivacaine 
with 10 mcg of Fentanyl intrathecally. Since this study was conducted to 
evaluate the effect of EVE on low dose intrathecal Bupivacaine, 5mg of 
0.5% hyperbaric Bupivacaine with 10 mcg of Fentanyl was used followed 
by 6 ml of saline epidurally in study group. C.Loubert
[13 ]
 et al used 5 ml of 
saline epidurally. 
In most of the studies conducted on non parturients (eg: TURP
 [11 ]
, 
lower limb surgeries
 [8]
) EVE was done with 10ml of saline. But in 
parturients, EVE saline was restricted to 5-6ml. Due to the physiological 
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changes occurring during pregnancy, there is decrease in the volume of the 
epidural space. So lesser volume of saline was used for EVE in this group.    
All the patients were positioned in lateral position during the 
procedure. Asha Tyagi et al
 [12 ]
 and John Chiraynth, Radhika Dhanapal
[8 
 
in their study stated that EVE if done in lateral position, accentuates the 
spread of SAB in comparision to sitting position.  
         CSEA could be performed either as Single Space Technique (SST) or 
Double Space Technique (DST). C. Loubert et al
[ 13] 
and N. Beale et al
[31 ]
 
in their study have done CSEA by needle through needle technique of SST 
where intrathecal injection was followed by insertion of epidural catheter, 
whereas in DST epidural catheter is placed in the epidural space first and 
then the drug is injected intrathecally in another vertebral space. During this 
study CSEA with DST was followed in both the groups. Using CSEA by 
NTN technique makes the procedure very simple when compared to DST. 
But injecting the drug intrathecally before the insertion of epidural catheter 
might cause deposition of hyperbaric drug in the lower levels, decreasing 
the cephalad spread of the drug.  
 
 
 
77 
 
SENSORY AND MOTOR BLOCK PROFILE: 
Maximum sensory blockade level: [ SMAX ]  
Ben david  B et al
[ 32]
 in their study administered 5 mg of 0.5% 
hyperbaric bupivacaine intrathecally without EVE and was found to have 
inadequate anaesthesia in 50% of the patients. Guasch E et al
 [33 ]
 found that 
all the 6 patients in their study who received only 5mg of 0.5% Bupivacaine 
as spinal anaesthesia required rescue analgesia. The recommended level of 
anaesthesia for caesarean delivery of T4
[34 ]
 was not achieved with low dose 
intrathecal Bupivacaine alone according to the above studies. 
In this study the difference in maximum sensory block attained 
between the groups was statistically insignificant. The mean sensory levels 
were T3.8 in group S and T3.43 in group E, which has shown that 
„Adequate sensory level of blockade‟ was achieved even with low dose 
intrathecal Bupivacaine which was augmented by EVE. 
Results in this study correlated with the study conducted by Lew E et 
al
[ 9]
. A sensory level of C7-T4 was obtained in both EVE and SAB group in 
their study. This could be explained as a result of „volume effect’ of epidural 
saline resulting in the „squeezing‟of CSF and more extensive spread of 
subarachnoid local anaesthetic. 
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John Chiraynth, Radhika Dhanapal
[8 ]
 study also has shown that 
epidural normal saline extended the block. In their study sensory level in 
group which received local anaesthetic for EVE, was higher than the group 
which received normal saline for EVE, which in turn was higher than the 
group which did not receive EVE. 
C. Loubert et al
 [13]
 in their study did not show any benefit of EVE in 
raising the level of the block. As per the author, that might be from the fact 
that both the spinal injection of hyperbaric Bupivacaine and EVE were 
performed in sitting position where baricity is a determinant factor of local 
anaesthetic spread within subarachnoid space. Gravity might have 
counteracted the cephalad spread of the hyperbaric Bupivacaine.    
 Time required for maximal sensory blockade: [TS MAX] 
                   This study did not demonstrate a statistically significant 
difference in the time required for attaining maximal sensory level. It 
correlates with the Doganci et al
 [10 ]
 and Lew et al
 [ 9]
 studies.       
 Maximum motor block attained: [ MMAX ] 
                    The motor block was assessed by using modified Bromage 
score. In group S maximum motor blockade was 2.90  0.30 and in group E 
1.93  0.45 which were statistically significant. It was similar to that of Lew 
E et al 
[ 9]
 and C Loubert et al
 [13 ]
 studies. 
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                    C. Loubert et al
[13]
 put forward a hypothesis to explain their 
findings. The injection of epidural saline may accelerate the spread of a 
fraction of the spinal Bupivacaine towards the sacral segments by means of 
a volume effect. Upon assuming the wedged supine position, it is possible 
that some amount of Bupivacaine be trapped in the sacral region of the dural 
sac. As sacral roots do not contribute to motor function of lower limbs, EVE 
group patients might have a lower Bromage score. 
Time for sensory regression to T10 dermatome: [TREG-10] 
                   The time for sensory regression in group S verses group E was 
134  23.59 versus 108  17.12 minutes which was statistically significant 
demonstrating an early sensory regression of block in EVE group. This 
result was similar to those of John Chiraynth and Radhika Dhanapal
 [8 ]
 
study. 
                  The early sensory regression might be explained by the fact that 
the concentration of drug getting diluted in CSF is lesser in group E than in 
group S. Concentration of the drug falls below the „concentration minimum‟ 
earlier in group E than the group S where higher concentration of drug is 
used, leading to faster sensory recovery.  
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 Time for complete motor recovery: [ TM0 ] 
                  The patients in group E showed a faster motor recovery as 
compared to group S (79.50   17.39 minutes VS 183  23.216 minutes) 
which was statistically significant. This correlate with result of Lew et al
 [9 ] 
study where patients in group E recovered completely from motor blockade 
within 73  33 minutes as compared to group S who took 136  32 minutes. 
                  Walter J Trautman et al
 [ 6]
 during their study on eight 
volunteers assessed the motor strength by isometric force dynamometer at 
knee and ankle after EVE using either saline or Bupivacaine and 
demonstrated a faster motor recovery with epidural saline.  
               The early motor regression might also be because of the fact that 
the lower concentration of the drug in CSF, in group E leads to early fall in 
the concentration of drug below the „concentration minimum‟ for motor 
blockade.   
              Early motor recovery relieves maternal anxiety as she can move her 
legs freely without any pain. 
Time for request of rescue analgesia: [ TPAIN ] 
                   The patients in group S complained of pain after 164.33    
24.02 minutes and in group E rescue analgesia after 130.67  15.01 minutes. 
A significant „p‟value of 0.000 was observed. The early regression of the 
81 
 
sensory block in EVE group also explains the early request for rescue 
analgesia. 
                   The early regression of blockade could be considered as an 
advantage and also a disadvantage. Advantage because the recovery of the 
blockade can be ensured by the anaesthesiologist early and patient can be 
discharged earlier from PACU. It is a disadvantage, because patient 
complains of pain earlier and early commencement of post operative pain 
management is necessary.  
VISUAL ANALOGUE SCORE (VAS): 
                   VAS assessed at the time of incision, were comparable in both 
the groups as an insignificant „p‟ value of 0.321 was observed. 
                   During this study, one patient complained of pain after 25 
minutes of commencement of the surgery in group E. VAS score of 5 was 
recorded. Patient was reassured and 3 ml of 2% lignocaine was administered 
through epidural catheter. After 5 minutes, surgery was continued. Later 
VAS scores were 0 in this patient throughout the surgery. 
                   This study has demonstrated that adequate analgesia required for 
the surgery was provided by low doses of intrathecal drug when it was 
augmented with EVE. 
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APGAR SCORE: 
                    APGAR scores were used to assess the neonatal well being at 1 
and 5 minutes after the delivery.                
                    In this study APGAR Scores did not show any significant 
difference between the two groups, showing both the techniques did not 
have any adverse effect on fetal well being. 
                    These results are in correlation with the studies conducted by 
Asha Tyagi et al
[ ]
 and  Lew E et al
[ ].
. 
 
HEMODYNAMIC STABILITY: 
                   When comparing the intraoperative pulse rate and Mean Arterial 
Pressure (MAP) between the groups, both the groups showed a fall in MAP 
below the basal values. But patients in group S had a lower MAP than that 
of group E. The difference was statistically significant between 12.5 and 20 
minutes of intraoperative period. Since the onset of action of intrathecal 
Bupivacane is about 5-8 minutes after intrathecal injection, a higher fall in 
blood pressure was noted in group S in those intervals. 
                   In group E, the concentration of drug used intrathecally was 
low, leading to lesser sympathetic blockade than the conventional dose of 
drug. Thus intraoperative hemodynamics were better than the group S. The 
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Ephedrine requirement in group E was also lesser than the group S [9.8  
6.2 mg versus 15.8  6.6 mg ]. This correlates with the Lew et al
[ ]
  study[12 
 11 mg versus 16  15 mg ].  
               Pulse Rate between the groups were not statistically significant. 
 
MATERNAL SATISFACTION SCORES: 
                   The difference in maternal satisfaction scores were statistically 
insignificant among the groups, indicating adequate analgesia was achieved 
in both the groups. 
                  In both the groups adequate rescue analgesia was provided post 
operatively by intermittent boluses of 0.125% of epidural Bupivacaine, 
which gave immediate pain relief. In intramuscular mode of analgesia there 
would be a delay in onset of action, during which patient might experience 
pain. Because adequate analgesia was maintained in intraoperative and also 
in post operative period better maternal satisfaction scores were observed in 
both the groups. 
ADVERSE EFFCTS: 
                   83.3% in group E and 90% in group S developed hypotension. 
Though the incidence of hypotension was similar in both the groups MAP 
was maintained higher in group E than the group S. 
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                     One patient in group E developed pruritis. One patient in each 
group developed shivering. 
  LIMITATIONS OF THE STUDY: 
    1. Higher incidence of hypotension was seen even in group E. 
Hypotension is one of the common and dangerous complication for 
both mother and fetus.when the cause for this higher incidence was 
analysed retrospectively, probably instead of 10 ml/kg of preloading 
20 ml/ kg or atleast 15 ml/ kg of preloading would have decreased the 
incidence of hypotension atleast in group E. 
 2. APGAR score was used in this study, which has shown fetal wellbeing 
in both the groups. Umbilical cord blood analysis is a better tool. 
3. Early regression of sensory levels in group E due to low intrathecal 
dose of drug, lead to earlier request for first rescue analgesia. So rescue 
analgesia should be commenced earlier, if this technique is preferred.  
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                                    SUMMARY 
              Sixty patients of ASA I and II undergoing elective caesarean 
sections were randomly assigned into two groups namely group S and group 
E. Combined Spinal Epidural technique was performed using double space 
technique in lateral position in all the patients. Group S received  9 mg of 
0.5% hyperbaric Bupivacaine with 10 mcg of Fentanyl  intrathecally and 
group E received 5mg of 0.5% hyperbaric Bupivacaine with 10 mcg of 
Fentanly intrathecally followed by EVE with 6ml of normal saline. 
           Intraoperatively pulse rate, MAP, SP02 was monitored. Maximum 
sensory and motor block achieved, time required to achieve maximum 
blockade level, time required for regression of the block, time of first 
request of pain, incidence of adverse effects, dose of Ephedrine required, 
Visual Analogue Score, Maternal satisfaction scores were compared 
between the two groups. Post operative analgesia was maintained with 
epidural topups of 0.125% Bupivacaine.  
Statistical analysis was done using chi square test and a „p‟value of < 0.05 
was taken as significant. This study showed that:  
         1. Similar sensory blockade levels were achieved between both the 
groups. 
        2. Time required for attaining maximum sensory block was similar in 
both groups.  
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       3. Lower Bromage scores are seen with EVE of low dose intrathecal 
drug.  
       4. Faster sensory and motor regression was seen in with EVE of low 
dose intrathecal drug.   
      5. Intraoperative hemodynamics was better with EVE of low dose 
intrathecal drug.  
     6.  Incidence of adverse effects was similar in both the groups. 
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                                       CONCLUSION 
               Comparing to conventional dose spinal anaesthesia, Epidural 
Volume Expansion of low dose intrathecal Bupivacaine in caesarean 
sections provides 
                     1. Adequate intraoperative anaesthesia. 
                     2. Faster motor and sensory recovery. 
                     3. Better hemodynamic stability.  
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PROFORMA 
A COMPARATIVE STUDY OF LOW DOSE INTRATHECAL 
BUPIVACAINE WITH EPIDURAL VOLUME EXPANSION AND 
CONVENTIONAL DOSE SPINAL ANAESTHESIA IN CAESAREAN 
SECTIONS 
 
STUDY GROUP:         
NAME   :                                                                 
AGE      :                                                                          HEIGHT:               
IP NO    :                                                                          WEIGHT:              
UNIT     :  
PRE OPERATIVE: 
PR  :                                                      Hb:                        BT:              CT: 
 BP :                                                      Blood  Grouping:              B.Glucose:   
 CVS:                                                     B .Urea   :                         S.  Creatinine : 
RS:                                                         Urine analysis:   Glucose          /Albumin           
P/A:                                                        ECG        
Airway:           
ASA  Physical  Status: 
 
 
 
INRA OPERATIVE: 
   Maximal  Sensory level  [ SMAX ]                      : 
   Time  for  Maximum  Sensory  level [TMAX]    :  
   Maximal  Bromage  Score [MMAX]                   : 
  Time for  Maximal  Bromage Score [TM.MAX]   : 
                                                        VAS Score   : 
                             APGAR  SCORE    -1 min    : 
                                                             - 5 min    : 
  PR  MAP  SP02 Drugs Sensory  
Level 
Bromage 
score 
T0       
T2.5       
T5       
T7.5       
T10       
T12.5       
T15       
T17,5       
T20       
T22.5       
T25       
T27.5       
T30       
T35       
T40       
T45       
T50       
T55       
T60       
 
Duration  of  Surgery :              min                          Total  Ephedrine:            mg   
Intra Venous  Fluids   :             ml        
     
POST  OPERATIVE  PERIOD: 
Period  for  block regression to level to T10 [TReg-10] : 
Period for complete regression of motor  block [TM0]          : 
Time of request  for 1 st post operative Analgesia[TPAIN]       : 
 
 PERI  OPERATIVE  COMPICATIONS: 
 
 
Intra 
Operative 
Post Operative Treatment 
Hypotension 
(SBP < 100 mmHg/ 
MAP< 20%  base line) 
   
Bradycardia 
( PR < 50 /min) 
 
   
Nausea/ 
Vomiting 
 
   
Pruritis 
 
   
Shivering 
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1 E KAVIARASI 24 150 61 86 93 99 55 T2 7.5 100 140 2 7.5 95 0 9 10 12 HYPOTENSION 
2 E RADHA 23 154 50 98 94 99 45 T4 5 125 150 2 5 105 0 8 10 0 SHIVERING 
3 E PUNEETHA 32 156 50 90 90 98 55 T5 5 100 135 1 7.5 100 5 10 10 6 HYPOTENSION 
4 E KALAIVANI 23 152 52 111 88 99 60 T4 5 90 120 2 10 50 0 8 9 12 HYPOTENSION 
5 E SEETHALADEVI 21 158 64 104 79 99 40 T4 5 80 100 2 7.5 55 0 8 10 18 HYPOTENSION 
6 E LAKSHMI 23 153 75 99 83 99 50 T4 7.5 90 100 2 10 60 0 9 10 6 HYPO/SHVRNG 
7 E SAMIYAMMAL 26 152 78 78 82 99 55 T2 5 100 135 2 7.5 100 0 9 9 18 HYPOTENSION 
8 E MALA 25 160 54 98 79 98 60 T4 7.5 120 150 1 7.5 60 0 9 10 12 HYPOTENSION 
9 E MAHALAKSHMI 28 153 70 102 70 99 65 T2 5 120 150 2 10 70 0 8 10 18 HYPOTENSION 
10 E ELAYARASI 25 157 80 106 68 98 70 T4 10 85 110 2 10 90 0 9 10  NIL 
11 E MAHESHWARI 29 158 70 98 88 99 60 T4 7.5 120 130 2 7.5 75 0 9 9 6 HYPOTENSION 
12 E SATHYA 32 150 68 108 64 99 60 T2 7.5 100 130 2 10 100 0 10 10 18 HYPOTENSION 
13 E KALAIVANI 23 154 68 90 97 99 55 T2 5 140 150 2 7.5 115 0 9 9 12 HYPOTENSION 
14 E BHARATHI 30 156 58 98 96 98 45 T4 5 120 130 2 10 50 0 9 10 12 HYPOTENSION 
15 E SANGEETHA 26 160 56 86 84 98 40 T4 5 100 130 1 7.5 70 0 9 10 18 HYPOTENSION 
MASTER CHART 
GROUP E 
                                                                               
 
 
   
 
16 E VEERAMAL 24 154 54 90 82 98 45 T2 5 100 120 2 7.5 60 0 8 9 18 HYPOTENSION 
17 E RENUKA 28 150 60 100 68 99 50 T4 7.5 90 110 2 10 75 0 9 10 12 HYPOTENSION 
18 E DEVI 32 158 68 96 82 99 55 T2 2.5 125 135 2 5 75 0 8 10 12 HYPOTENSION 
19 E SARADA 23 160 78 104 68 99 50 T4 7.5 140 150 2 7.5 60 0 9 10 6 HYPOTENSION 
20 E GOMATHI 27 154 70 98 94 99 50 T6 5 120 135 1 7.5 80 0 10 10 6 NIL 
21 E SENTHAMARAI 31 154 75 90 94 99 60 T2 5 120 135 2 7.5 75 0 7 9 18 HYPOTENSION 
22 E PRIYA 19 150 70 100 80 99 65 T4 7.5 115 130 2 10 65 0 9 10 6 HYPOTENSION 
23 E MUTHULAKSHMI 27 156 74 96 88 99 40 T4 7.5 105 130 2 10 90 0 9 10 12 NIL 
24 E VENNILA 23 154 74 98 78 99 45 T4 5 80 100 3 7.5 100 0 8 9 6 HYPOTENSION 
25 E DURGA 25 150 70 94 80 98 50 T2 5 130 145 2 7.5 80 0 9 10 12 HYPOTENSION 
26 E VEERAYE 25 156 78 98 86 98 60 T6 10 125 140 2 10 80 0 9 10 6 NIL 
27 E MAHARANI 29 162 78 84 84 99 65 T4 7.5 100 140 2 10 90 0 9 10 6 HYPOTENSION 
28 E RAMYA 25 154 74 88 86 98 40 T4 5 100 130 2 7.5 95 0 8 9 6 HYPOTENSION 
29 E FATHIMA 28 165 76 94 70 99 40 T2 5 90 120 3 10 80 0 9 10 12 HYPOTENSION 
30 E SUMATI 28 140 78 96 92 98 60 T2 5 125 140 2 7.5 85 0 9 10 12 HYPOTENSION 
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1 S KAVITHA 24 157 84 88 98 99 50 T4 5 150 180   3   7.5 230 0 9 10 18 HYPOTENSION 
2 S ANITHA 32 152 64 90 85 98 60 T4 5 130 200   3 5 210 0 10 10 18 HYPOTENSION 
3 S SHANTHI 29 158 64 96 88 99 55 T2 10 140 200   3 10 200 0 10 10 24 PRUTS/HYPTN 
4 S RAGINI 23 156 70 108 87 99 40 T6 7.5 160 180   3 10 180 0 9 10  NIL 
5 S LATHA 25 158 50 78 77 99 45 T4 5 110 180   3 5 200 0 8 10 18 HYPOTENSION 
6 S SATHYA 20 161 60 102 92 99 40 T2 5 130 180 3 7.5 210 0 8 9 18 HYPOTENSION 
7 S PUNEETHA 22 150 56 108 88 99 50 T6 5 140 190 3 7.5 200 0 10 10 24 HYPOTENSION 
8 S ANUSIYA 24 150 50 90 80 99 50 T4 7.5 150 190 3 7.5 190 0 10 10 12 HYPOTENSION 
9 S USHA 32 156 65 100 89 98 60 T4 2.5 150 160 2 5 180 0 9 10 6 HYPOTENSION 
10 S SUMATY 21 157 55 90 89 98 50 T2 7.5 160 180 3 10 180 0 10 10 12 HYPOTENSION 
11 S KANIMOZHI 29 154 55 88 96 99 55 T4 5 100 180 3 7.5 200 0 10 10 12 HYPOTENSION 
12 S RAJALAKSMI 25 160 68 96 93 99 60 T2 2.5 140 160 3 5 180 0 8 10 18 HYPOTENSION 
13 S BHANUMATI 23 154 70 90 84 99 40 T4 5 90 150 3 5 180 0 9 9 18 HYPOTENSION 
14 S KALAIARASI 26 150 63 86 100 98 45 T6 5 90 100 3 5 160 0 8 9 24 HYPOTENSION 
15 S SUBHULAKSMI 28 154 55 92 73 99 60 T4 7.5 165 180 3 7.5 200 0 9 10 18 HYPOTENSION 
                                                                               
 
 
16 S SAMSUNISHA 23 160 78 108 84 99 50 T2 7.5 150 160 3 10 180 0 9 10 18 HYPOTENSION 
17 S VANATHI 26 158 70 104 78 99 55 T4 5 160 185 3 7.5 200 0 9 10 12 HYPOTENSION 
18 S PREETHA 28 154 68 86 90 99 50 T4 5 165 165 3 7.5 180 0 10 10 12 HYPOTENSION 
19 S JEEVA 25 160 78 86 76 99 60 T6 7.5 150 160 2 10 180 0 10 10 6 HYPOTENSION 
20 S TAMILARASI 22 156 58 78 86 99 60 T4 5 145 180 2 7.5 210 0 9 9 18 HYPTN/SHVRG 
21 S ANANDAVALLI 23 156 70 90 78 99 60 T4 7.5 110 130 3 10 150 0 8 10 18 HYPOTENSION 
22 S CHANDRA 30 160 68 106 80 99 50 T2 5 150 160 3 5 180 0 9 9 24 HYPOTENSION 
23 S RUKMANI 24 155 70 90 98 98 45 T4 7.5 90 120 3 7.5 120 0 9 10 12 HYPOTENSION 
24 S REVATHY 28 158 70 80 90 99 40 T4 5 120 135 3 5 140 0 9 9 12 HYPOTENSION 
25 S RAMYA 24 154 68 96 84 99 50 T4 5 130 150 3 7.5 180 0 8 9 24 HYPOTENSION 
26 S MALA 23 162 78 88 70 98 50 T4 2.5 120 130 3 5 150 0 8 10 18 HYPOTENSION 
27 S DEVI 22 156 68 86 76 98 60 T6 5 160 180 3 7.5 200 0 9 10  NIL 
28 S ESWARI 26 150 68 88 84 99 55 T2 5 150 165 3 7.5 180 0 9 9 24 HYPOTENSION 
29 S LAKSHMI 24 158 80 90 104 99 50 T4 7.5 110 150 3 7.5 180 0 10 10 18 HYPOTENSION 
30 S SUGUNA 22 160 70 92 86 99 45 T4 5 115 150 3 7.5 160 0 9 10 18 HYPOTENSION 
 
 
  
 GROUP E                                                                                           MEAN  ARTERIAL BLOOD 
MIN 2.5 5 7.5 10 12.5 15 17.5 20 22.5 25 27.5 30 40 50 60 75 90 105 120 
1 70 68 70 68 68 70 74 64 68 78 80 82 82 80 84 78 82 82 82 
2 74 64 68 68 60 70 68 64 64 70 70 70 74 70 72 76 70 80 80 
3 68 68 58 60 62 64 78 78 80 70 84 80 84 82 80 74 76 80 84 
4 70 76 78 88 76 76 68 68 70 76 70 86 76 70 72 70 74 72 70 
5 75 86 77 77 78 68 78 76 68 70 68 68 70 70 68 68 70 72 70 
6 70 74 68 70 68 64 68 70 70 68 70 64 70 70 68 64 68 72 84 
7 75 86 77 68 70 72 70 76 70 72 72 68 68 74 78 80 88 80 80 
8 70 68 70 66 64 68 70 70 72 68 76 72 70 68 70 74 76 76 80 
9 72 74 73 70 76 80 82 86 80 82 82 84 78 70 72 74 72 72 74 
10 70 54 56 55 57 56 54 68 68 69 72 72 70 72 72 74 78 80 80 
11 78 57 59 65 63 66 57 68 60 67 73 75 78 80 82 82 80 78 76 
12 90 80 81 82 70 73 74 70 72 70 70 74 88 90 90 94 90 92 90 
13 86 85 81 75 73 79 73 61 64 68 71 71 74 78 78 74 80 72 70 
14 70 74 68 86 73 57 61 60 73 66 66 71 76 74 72 70 88 84 84 
15 86 82 70 68 78 80 80 78 78 76 74 72 70 74 70 72 74 70 72 
16 70 54 50 60 63 62 60 64 64 68 86 70 72 80 82 70 74 68 74 
17 70 68 86 73 57 61 60 73 66 66 71 76 81 74 68 70 72 72 74 
18 78 68 64 62 68 68 60 79 80 80 78 80 90 86 84 79 80 80 83 
19 70 68 68 56 70 70 68 64 68 68 70 72 70 70 74 80 82 80 82 
20 68 64 68 70 64 62 70 74 70 68 68 70 72 70 72 70 71 70 71 
21 72 62 62 64 70 72 74 74 78 80 78 78 70 80 88 90 96 84 82 
22 68 74 64 68 70 72 72 74 76 80 76 80 76 70 70 80 84 82 86 
23 92 97 108 80 78 68 64 79 70 78 81 82 78 78 80 78 78 70 78 
24 90 78 76 78 68 60 76 70 70 78 70 76 78 78 78 76 70 70 70 
25 84 68 68 70 64 70 74 78 76 70 64 68 68 70 70 84 80 70 72 
26 70 62 65 64 62 70 78 72 74 72 78 70 74 72 70 72 74 70 74 
27 86 64 68 68 70 70 72 74 70 78 70 68 80 76 74 74 70 70 70 
28 68 64 70 70 68 70 68 70 70 68 76 74 78 70 74 72 86 80 78 
29 68 68 56 56 68 70 76 64 68 70 72 70 68 70 64 70 68 70 70 
30 68 58 65 63 66 60 67 73 75 78 80 80 82 82 80 84 80 80 80 
 GROUP S                                                                                    MEAN ARTERIAL BLOOD PRESSURE 
 2.5 5 7.5 10 12.5 15 17.5 20 22.5 25 27.5 30 40 50 60 75 90 105 120 
1 70 66 66 83 96 90 83 83 86 83 93 96 93 83 93 98 96 98 98 
2 74 63 66 63 65 65 65 61 69 68 72 76 68 80 82 82 78 82 80 
3 80 76 78 78 85 80 85 85 85 78 78 76 78 82 84 86 88 80 86 
4 84 80 76 62 62 68 68 72 76 80 80 88 84 78 82 80 78 76 78 
5 72 78 79 73 74 79 75 77 88 86 82 91 94 90 78 78 72 78 86 
6 84 83 81 76 71 75 68 71 78 74 76 78 71 76 80 86 84 86 86 
7 83 71 71 66 66 65 65 58 62 72 72 81 82 76 82 88 80 86 78 
8 70 78 78 76 68 68 78 70 74 76 76 78 78 76 74 78 84 88 86 
9 90 64 68 65 80 57 56 55 104 80 90 100 94 94 80 100 102 98 100 
10 80 70 74 62 67 53 53 59 60 64 60 68 74 80 80 70 74 74 78 
11 88 82 85 84 70 70 68 66 58 56 68 75 78 70 80 89 80 80 84 
12 86 70 77 84 90 84 78 75 81 80 86 86 78 80 74 86 88 86 76 
13 80 80 72 68 66 56 54 60 70 74 74 68 60 68 64 66 78 70 72 
14 83 86 85 86 85 66 66 66 66 68 68 70 74 74 78 80 68 70 70 
15 68 71 68 56 66 66 62 68 66 60 76 70 61 68 70 68 70 76 76 
16 80 90 80 70 83 70 81 86 83 70 78 78 83 84 86 80 86 84 84 
17 68 60 66 60 62 63 56 57 65 70 81 70 74 72 73 74 86 86 84 
18 70 66 68 68 70 72 74 78 80 80 70 74 72 74 76 79 78 82 84 
19 74 60 54 60 70 68 58 54 70 70 76 70 68 70 74 76 74 70 70 
20 83 71 71 66 66 65 58 62 72 72 80 78 76 76 74 76 74 78 76 
21 80 70 74 62 67 53 53 59 60 58 54 60 54 56 64 70 76 68 70 
22 86 70 78 70 72 68 66 60 64 64 68 70 80 80 78 80 80 70 70 
23 85 84 60 56 56 60 64 62 68 70 74 74 76 76 70 70 72 72 80 
24 70 78 60 58 56 58 60 60 64 62 60 60 64 84 80 72 70 74 76 
25 80 72 70 60 60 64 56 58 58 60 64 68 68 70 82 72 70 70 74 
26 70 68 68 68 70 56 60 62 64 64 70 72 72 70 72 72 70 74 70 
27 76 70 68 56 58 54 56 58 60 62 62 70 72 70 70 72 74 70 72 
28 70 68 56 58 60 64 66 60 64 64 70 72 70 84 84 82 74 72 76 
29 80 64 68 66 68 64 70 72 72 76 70 74 72 70 70 72 70 72 80 
30 70 60 56 66 58 56 68 68 70 70 72 68 70 72 84 84 80 80 80 
  
 
 
 
             
 
 
FIGURE 4:  ANATOMY OF SUB ARACHNOID BLOCK 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
FIGURE 6: EPIDURAL VOLUME EXPANSION 
 
 
 
 
 
 
  
 
 
 
 
 
 
FIGURE 8  BROMAGE SCORE 
 
 
 
 
 
 
 
  
 
 
 
 
 
FIGURE 5 
 
 
 
 
 
  
 
FIGURE 2:  CROSS SECTION OF SPINAL CORD 
 
 
FIGURE 3: SUPPORTS OF VERTEBRAL COLUMN 
 
 
 
 
  
 
FIGURE 1: ANATOMY OF VERTEBRAL COLUMN 
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     HUBER  NEEDLE WITH A BACK EYE 
                
 
     
ELDOR NEEDLES (Eldor, Coombs and Torrier modification) 
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